Wegovy (semaglutide) and sotrovimab will soon be available.
Wegovy (semaglutide) and sotrovimab will soon be available.
A new 500mg injection will soon be available.
A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.
Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Olinvyk injections and Qdolo oral solution are approved for the management of acute pain.
A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.
Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.
The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.
